医学
再狭窄
严重肢体缺血
经皮
腘动脉
外围设备
放射科
支架
血管内治疗
动脉疾病
外科
血管疾病
内科学
动脉瘤
作者
Ehrin J. Armstrong,Ehrin J. Armstrong
出处
期刊:Journal of Thoracic Disease
[AME Publishing Company]
日期:2020-07-04
卷期号:12 (4): 1681-1694
被引量:21
标识
DOI:10.21037/jtd.2019.12.130
摘要
: More than 200 million people worldwide have peripheral artery disease (PAD) or its most severe manifestation, critical limb ischemia (CLI). While endovascular treatment has become first line therapy in most cases, a number of challenges remain for optimal treatment of femoropopliteal (FP) or infrapopliteal (IP) disease, especially when these lesions are severely calcified, chronic total occlusions (CTOs) or in-stent restenosis (ISR). Continued evolution of technologies has significantly improved the outcomes for endovascular treatment. A number of new devices are in the pipeline right now, including new paclitaxel eluting stents and balloons, intravascular lithotripsy to treat severely calcified lesions, adventitial delivery of anti-restenotic agents to limit restenosis rates, and percutaneous femoro-popliteal bypass.
科研通智能强力驱动
Strongly Powered by AbleSci AI